Five-Year Extension of $32 Million Contract for RIS Technology Awarded to Pro Medicus

2 min read | October 16, 2024 10:59 PM AEDT | By Team Kalkine Media

Google News:

Five-Year Extension of $32 Million Contract for RIS Technology Awarded to Pro Medicus — Image source: Shutterstock

Recent News

Santos (ASX:STO) After the Takeover Collapse: Bargain or Value Trap?

Why Pro Medicus (ASX:PME) Is Leading the Growth Stock Conversation

Is 360 (ASX:360) Amid ASX 200 Revealing Growth’s New Reality?

Why 360 (ASX:360) ASX 200 Is Facing a New Growth Test

Make Kalkine Media
My Trusted Source

Highlights:

Contract Extension: Pro Medicus Ltd has secured a five-year contract extension valued at a minimum of $32 million with a prominent Australian Radiology Network.

Technological Leadership: The contract pertains to PME’s Radiology Information Systems (RIS), which enhances various operational processes within radiology practices.

Market Performance: Despite the contract extension, PME shares saw a minor decline of 0.39%, trading at $189.62 during the day.

Pro Medicus Ltd (ASX:PME), a leading healthcare informatics company, has announced a significant five-year contract extension with a major Australian Radiology Network. The extension is valued at a minimum of $32 million, reflecting the growing demand for advanced medical software solutions in the radiology sector.

This contract relates to PME’s Radiology Information Systems (RIS) product, which streamlines various operational tasks within radiology practices. The RIS software offers capabilities in patient registration, billing, scheduling, typing, and financial reporting, facilitating efficient management and enhanced service delivery for healthcare providers. The extension of this contract, negotiated at an increased fee, underscores PME's reputation and influence in leveraging healthcare technology effectively.

Dr. Sam Hupert, the CEO of Pro Medicus, highlighted that this contract extension reinforces the company’s leadership position in the Australian market for RIS solutions. By continuing to provide advanced software that meets the evolving needs of radiology practices, PME is well-positioned to capitalize on the growing integration of technology in healthcare.

As of 13:08 AEDT, shares in Pro Medicus were trading at $189.62, experiencing a slight decline of 0.39% since the market opened. This performance reflects broader market dynamics while the company continues to secure substantial contracts that enhance its growth trajectory.

For those interested in the latest developments in Pro Medicus and its role in the healthcare informatics sector, discussions on platforms like HotCopper offer insights into market sentiments and trends. Engaging with these discussions can provide valuable perspectives on the company’s ongoing impact in the industry.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.